Fibronostics' LIVERFASt provides early detection and monitoring for patients with NAFLD & NASH. Where the current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool, the LIVERFASt products are easy to use with economical advantages, and have proven clinical value.
Location: United States, Florida, Orlando
Employees: 11-50
Total raised: $8M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | SPRIM Vent... | sprim.com |
| - | Elev8.vc | elev8.vc |
| - | SPRIM Glob... | sprim.net |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.08.2020 | Series A | $8M | - |
Mentions in press and media 9
| Date | Title | Description |
| 27.10.2025 | Fibronostics Acquires Stone Clinical Laboratories to Advance MASH/MASLD Diagnostics | Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. NEW ORLEANS, Oct. 27, 2025 /PRNewswire/ -- Fibronostics, a global leader in non-invasive diagnostics for metabo... |
| 07.12.2020 | Fibronostics and Fatty Liver Foundation Announce a Patient Education Partnership | |
| 25.08.2020 | Daily funding roundup - August 25th, 2020 | RNAimmune has raised $2.4M; Stratify secured $4.9M; Fibronostics landed $8M RNAimmune: RNAimmune develops mRNA-based therapeutics and vaccines (it was spun out of another biotech company called Sirnaomics). RNAimmune has raised $2.4 million... |
| 24.08.2020 | Fibronostics Raises $8M in Series A | ORLANDO, FL, Fibronostics announced today that it has secured $8 million in series A funding, led by AT Capital. >> Click here for more funding data on Fibronostics >> To export Fibronostics funding data to PDF and Excel, cl... |
| 24.08.2020 | Fibronostics Raises $8M in Series A Financing | Fibronostics, a Singapore & New York-based company providing non-invasive, algorithmic diagnostics for NASH patients, secured $8 in Series A funding. The round was led by AT Capital and Elev8.vc. The financing will accelerate the commer... |
| 24.08.2020 | Fibronostics Raises $8 Million in Series A Financing | |
| 24.08.2020 | Fibronostics Raises $8 Million in Series A Financing | Fibronostics, a global company providing non-invasive, algorithmic diagnostics for NASH patients, announced today that it has secured $8 million in series A funding. The financing round was led by AT Capital, a leading private investment fi... |
| 24.08.2020 | Fibronostics Raises $8 Million in Series A Financing | - |
| 07.06.2019 | AC Health Announces Investment in Fibronostics | Ayala Healthcare Holdings, through its technology arm, Vigos, expanded its digital portfolio with a recent investment in SPRIM’s sister company, Fibronostics. The agreement was signed by AC Health President and CEO, Paolo Borromeo, AC Healt... |